Zombré takes the helm as the French pharmaceutical giant looks to deepen its footprint in the American market. His mandate focuses on scaling the company’s omnichannel presence and strengthening ties with both medical professionals and retail consumers. The appointment follows a period of robust performance, highlighted by the 32% growth of the Cicalfate+ Restorative Protective Cream.

With nearly two decades at the company, Zombré brings significant international experience to the role. He previously served as General Director in Spain, where he oversaw the transformation of the firm’s retail and digital strategies. Eric Ducournau, CEO of Laboratoires Pierre Fabre, noted that Zombré’s background in managing complex markets makes him the right choice to accelerate the company’s U.S. expansion. Zombré will oversee a portfolio that includes René Furterer and Klorane, aiming to leverage the scientific credibility of the brand to capture further market share.